首页> Human vaccines & immunotherapeutics> Development and validation of a predictive model for high-risk immune-related adverse events in gastric cancer patients treated with ICIs.

Development and validation of a predictive model for high-risk immune-related adverse events in gastric cancer patients treated with ICIs.

导出 OA

翻译打印收藏纠错

第一作者： Li,Ma

第一单位： Department of Radiology, Third Clinical College, Changzhi Medical College, Changzhi, Shanxi, China.;Department of Radiology, Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.

作者： Li,Ma ^[1] ; Junbo,Wu ^[2] ; Yunyi,Du ^[3] ; Min,Liu ^[3] ; Wenqing,Hu ^[4] ; Jun,Zhao ^[3] ; Yong'ai,Li ^[2]

作者单位： Department of Radiology, Third Clinical College, Changzhi Medical College, Changzhi, Shanxi, China.;Department of Radiology, Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China. ^[1] Department of Radiology, Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China. ^[2] Department of Oncology, Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China. ^[3] Department of Gastrointestinal Surgery, Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China. ^[4]

关键词 Immune checkpoint inhibitors (ICIs)complete blood cell (CBC)gastric cancer (GC)immune-related adverse events (irAEs)prediction model